China Journal of Leprosy and Skin Diseases ›› 2022, Vol. 38 ›› Issue (11): 837-841.doi: 10.12144/zgmfskin202211837

• Reviews • Previous Articles     Next Articles

Research advance in linear IgA bullous dermatosis

SONG Pingping, YANG Baoqi   

  1. Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250022, China
  • Online:2022-11-15 Published:2022-10-26

Abstract: Linear IgA bullous dermatosis (LABD) is an autoimmune bullous diseases characterized by continuous deposition of IgA autoantibody in the basement membrane zone (BMZ). It may be related to genetics, drugs, inflammatory diseases and tumor. The diagnosis of LABD should be confirmed by clinical manifestation,histopathological and immunofluorescence examination. Dapsone is the first line therapy for LABD. Biological agents have also been reported to treat the disease in recent years. This review summarizes epidemiological features, pathogenesis, clinical manifestations, laboratory examination, diagnosis and treatment of LABD.

Key words: linear IgA bullous dermatosis, diagnosis, therapy